Word: biotech
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...intervention that will slow the disease,” Brown said. “Obviously the real hope is a cure. Whether that is possible, I don’t know.”This summer, Kremer will be working on the launch of Avi Therapeutics, a for-profit biotech company that will try to commercialize academic research in the ALS field, according to Kremer. With these two companies, Kremer said he will continue to fight. “I want to save every ALS patient who lives today,” he said.LIVING AND LAUGHINGKremer has devoted the past...
...donations on their websites and given their boards oversight of the contributions. (Merck, which declined comment, began disclosing contributions last year, but its board doesn't supervise its giving.) Many companies fear alienating groups with competing political interests. Of 40 firms facing shareholder-sponsored disclosure resolutions, only one, the biotech firm Amgen, recommended a yes vote. Its measure passed last week...
...similar patents to target other drug makers with infringement claims. Signaling of the NF-kB molecule—the process at issue in Ariad’s dispute—is used by more than 200 compounds, including aspirin, according to Science magazine. Perhaps anticipating a future lawsuit, biotech company Amgen last week filed a pre-emptive motion asking a Delaware court to find Ariad’s patent invalid. The Thousand Oaks, Calif.-based firm also sought a ruling that its drug products do not infringe on the patent. Eli Lilly will contest the verdict by asking the judge...
...plans to revolutionize medical care by looking for cure for diseases like Parkinson’s, diabetes, Alzheimer’s and spinal cord injuries, Eli Broad said at the press conference. Broad also said he hopes the institute will serve as a catalyst in the economy of the biotech industry, “that it will foster the creation of jobs and encourage a robust tax base and have a far-reaching and long-lasting economic impact,” he said. Although the Harvard-MIT Broad Institute, created in 2004, also states as its mission finding treatment...
According to David Clapham, Castaneda Professor of Cardiovascular Research at Harvard Medical School and the principal investigator of Kirichok’s lab, understanding the function of CatSper can lead to the development of CatSper blockers to serve as contraceptives. Hydra Biosciences, a biotech company co-founded by Clapham, is already developing a drug that would specifically target CatSper...